Package 0378-3266-94

{"route": ["ORAL"], "spl_id": "a591eea6-af04-4207-b0f7-61fbada4719c", "openfda": {"nui": ["N0000175609", "N0000000176"], "unii": ["6PLQ3CP4P3"], "rxcui": ["197687"], "spl_set_id": ["508a418e-985f-4208-9324-2230655bb5c2"], "pharm_class_epc": ["Topoisomerase Inhibitor [EPC]"], "pharm_class_moa": ["Topoisomerase Inhibitors [MoA]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "20 CAPSULE in 1 CARTON (0378-3266-94)", "package_ndc": "0378-3266-94", "marketing_start_date": "20011022"}], "brand_name": "Etoposide", "product_id": "0378-3266_a591eea6-af04-4207-b0f7-61fbada4719c", "dosage_form": "CAPSULE", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "0378-3266", "generic_name": "etoposide", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Etoposide", "active_ingredients": [{"name": "ETOPOSIDE", "strength": "50 mg/1"}], "application_number": "ANDA075635", "marketing_category": "ANDA", "marketing_start_date": "20011022", "listing_expiration_date": "20261231"}